A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors. (7th November 2013) - Ansell, Stephen; Northfelt, Donald; Flinn, Ian; Burris, Howard; Dinner, Shira; Villalobos, Victor; Sikic, Branimir; Pilja, Lana; Yellin, Michael; Keler, Tibor; Davis, Thomas